Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Rheumatology
•
Inflammatory Bowel Disease
•
General Rheumatology
•
Infectious Disease
•
Tuberculosis
•
Gastroenterology
Would you hold all immunosuppressive medications for the first month of LTBI treatment, or just biologics?
Answer from: at Community Practice
This video might answer your question: QD Clinic - Lessons from the clinic - Dx and Treating LTBI with a TNFI inhibitor features Dr. Jack Cush
Sign in or Register to read more
8802
Related Questions
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
Is there a risk of hepatitis C activation with rituximab in a patient who has a history of HCV treated with antivirals and who is in sustained viral response?
How do you approach ongoing screening for TB in patients with a history of treated latent TB, but who have ongoing use of DMARDs and/or biologics given Quantiferon testing and PPD can remain positive?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
How do you approach managing nausea and GI side effects when initiating methotrexate?
How often do you see bony erosions in patients with Lyme arthritis?
What approaches can we take to initiate therapy and improve survival rates in patients with HLH?
How do you approach treatment of tuberculous scleritis in pregnancy?
Do you routinely consider FDG PET/CT imaging for workup of fever of unknown origin?
How would you approach additional workup and management of a patient with active Crohn’s disease, who has multiple lung and brain nodules, with lung pathology demonstrating necrotizing granulomatous inflammation and brain biopsy with granulomatous inflammation and medium-large vessel vasculitis?